Enhanced sensing performance of carbaryl pesticide by employing a MnO2/GO/e-Ag-based nanoplatform: role of graphene oxide as an adsorbing agent in the SERS analytical performance.

A functional ternary substrate was developed for surface-enhanced Raman scattering (SERS) sensing systems. MnO2 nanosheets were synthesized by a simple and controllable hydrothermal method, followed by the integration of graphene oxide (GO) nanosheets. Subsequently, MnO2/GO nanostructures were decorated with plasmonic Ag nanoparticles (e-AgNPs). The MnO2/GO/e-Ag substrate could enhance the SERS sensing signal for organic chemicals without the assistance of chemical bonds between those analytes and the semiconductor within the ternary substrate, which have been proven to promote charge transfer and elevate the SERS enhancement in previous studies. Instead, GO nanosheets acted as a carpet also supporting the MnO2 nanosheets and e-AgNPs to form a porous structure, allowing the analytes to be well-adsorbed onto the ternary substrate, which improved the sensing performance of the SERS platform, compared to pure e-AgNPs, MnO2/e-Ag, and GO/e-Ag alone. The GO content in the nanocomposite was also considered to optimize the SERS substrate. With the most optimal GO content of 0.1 wt%, MnO2/GO/e-Ag-based SERS sensors could detect carbaryl, a pesticide, at concentrations as low as 1.11 × 10-8 M in standard solutions and 10-7 M in real tap water and cucumber extract.

Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression.

Prostate cancer commonly affects the urinary tract of men and metastatic prostate cancer has a very low survival rate. Apelin belongs to the family of adipokines and is associated with cancer development and metastasis. However, the effects of apelin in prostate cancer metastasis is undetermined. Analysis of the database revealed a positive correlation between apelin level with the progression and metastasis of prostate cancer patients. Apelin treatment facilitates cell migration and invasion through inhibiting tissue inhibitor of metalloproteinase 2 (TIMP2) expression. The increasing miR-106a-5p synthesis via c-Src/PI3K/Akt signaling pathway is controlled in apelin-regulated TIMP2 production and cell motility. Importantly, apelin blockade inhibits prostate cancer metastasis in the orthotopic mouse model. Thus, apelin is a promising therapeutic target for curing metastatic prostate cancer.